The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has announced sweeping changes to regulations governing clinical trials, which it says are the largest
Novo Nordisk’s UK unit has been suspended as a member of the Association of the British Pharmaceutical Industry (ABPI) for two years due to what was described as “serious
Against a fairly bleak outlook for the UK economy, Jeremy Hunt’s latest budget as UK Chancellor of the Exchequer contained a number of measures that have been well receive
Pfizer UK president Susan Rienow will take the role of president of the Association of the British Pharmaceutical Industry (ABPI) on a full-time basis in May, following th
The UK government’s decision to raise the revenue clawback rate in the Statutory Scheme for controlling the costs to the NHS for purchasing branded medicines has prompted
The UK’s Office of Life Sciences (OLS) has commissioned an independent review of the country’s commercial clinical trials sector, following the publication of an industry
Software that can be used to monitor patients with neurodegenerative disorder amyotrophic lateral sclerosis (ALS) using their voice patterns has been granted breakthrough